Actively Recruiting
E-intervention on Subclinical Fear of Cancer Recurrence
Led by The University of Hong Kong · Updated on 2025-10-03
48
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
H
Health and Medical Research Fund
Collaborating Sponsor
AI-Summary
What this Trial Is About
The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.
CONDITIONS
Official Title
E-intervention on Subclinical Fear of Cancer Recurrence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cantonese- or Mandarin-speaking Chinese cancer survivors
- Recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
- Recently completed surgery as primary treatment
- Completed hospital-based adjuvant treatments (radiotherapy and chemotherapy) within the past six months
- Scored 13 to 21 on the fear of cancer recurrence-short form
You will not qualify if you...
- Non-Chinese ethnicity
- Metastatic cancer
- Current diagnosis of depression or psychosis or currently receiving psychological treatments
- Language or intellectual difficulties preventing understanding of the intervention content
- Limited or no Internet access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong
Actively Recruiting
Research Team
D
Danielle Ng, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here